Travere Therapeutics (TVTX) Assets Average: 2011-2025
Historic Assets Average for Travere Therapeutics (TVTX) over the last 12 years, with Sep 2025 value amounting to $546.9 million.
- Travere Therapeutics' Assets Average rose 3.63% to $546.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.9 million, marking a year-over-year increase of 3.63%. This contributed to the annual value of $691.5 million for FY2024, which is 5.37% down from last year.
- Per Travere Therapeutics' latest filing, its Assets Average stood at $546.9 million for Q3 2025, which was down 0.93% from $552.1 million recorded in Q2 2025.
- In the past 5 years, Travere Therapeutics' Assets Average ranged from a high of $810.9 million in Q4 2023 and a low of $527.8 million during Q3 2024.
- Its 3-year average for Assets Average is $653.6 million, with a median of $607.3 million in 2024.
- Per our database at Business Quant, Travere Therapeutics' Assets Average increased by 20.70% in 2021 and then plummeted by 32.74% in 2024.
- Travere Therapeutics' Assets Average (Quarterly) stood at $775.9 million in 2021, then decreased by 9.85% to $699.4 million in 2022, then climbed by 15.94% to $810.9 million in 2023, then crashed by 32.26% to $549.3 million in 2024, then rose by 3.63% to $546.9 million in 2025.
- Its last three reported values are $546.9 million in Q3 2025, $552.1 million for Q2 2025, and $571.5 million during Q1 2025.